Skip to main content
Premium Trial:

Request an Annual Quote

D. Gary Gilliland

Fred Hutchinson Cancer Research Center has named cancer genetics and precision medicine expert D. Gary Gilliland as its new president and director. Gilliland will assume his new role on Jan. 2. Gilliland previously was vice president of precision medicine at the University of Pennsylvania's Perelman School of Medicine. Before that he was an executive at Merck Research Laboratories and spent two decades at Harvard Medical School teaching medicine and investigating the genetic basis of blood cancers. His work has led to the development of a number of personalized cancer therapies.

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.